US government, drugmaker Gilead come to a head over patents for HIV antiviral Truvada
This page features: Cited Research Articles The US Department of Health and Human Services (HHS), and pharmaceutical company Gilead Sciences Inc. continue to wage war over government-owned patents for HIV pre-exposure prophylaxis (PrEP), or drugs to help prevent uninfected patients from contracting the virus. In this case, the US Patent Trial and Appeal Board on Feb. …
US government, drugmaker Gilead come to a head over patents for HIV antiviral Truvada Read More »